Neuroblastoma

Joseph Panoff; John Lucas; Luke Pater; Shefali Gajjar

doi:10.1007/978-3-319-43545-9_5

Neuroblastoma

Joseph Panoff, John Lucas, Luke Pater, Shefali Gajjar

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Approximately 650 cases of neuroblastoma are diagnosed in the United States each year. With an incidence of 10.2 cases per million, it is the most common cancer that arises during the first year of life and the most common extracranial solid malignancy, representing 8–10% of all pediatric malignancies. Neuroblastoma is also responsible for 15% of childhood cancer mortality (Attiyeh et al. 2005; Brodeur 1997; Maris 2010). The median age at diagnosis is 17 months, and the incidence of the disease quickly dissipates with increasing age (Fig. 5.1).

Original language	English (US)
Title of host publication	Pediatric Oncology
Publisher	Springer Verlag
Pages	87-110
Number of pages	24
Edition	9783319435442
DOIs	https://doi.org/10.1007/978-3-319-43545-9_5
State	Published - Jan 1 2018
Externally published	Yes

Publication series

Name	Pediatric Oncology
Number	9783319435442
ISSN (Print)	1613-5318
ISSN (Electronic)	2191-0812

Fingerprint

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Oncology

Cite this

Panoff, J., Lucas, J., Pater, L., & Gajjar, S. (2018). Neuroblastoma. In Pediatric Oncology (9783319435442 ed., pp. 87-110). (Pediatric Oncology; No. 9783319435442). Springer Verlag. https://doi.org/10.1007/978-3-319-43545-9_5

@inbook{c27a52ee6dd246fea37dedb30961d5ef,

title = "Neuroblastoma",

abstract = "Approximately 650 cases of neuroblastoma are diagnosed in the United States each year. With an incidence of 10.2 cases per million, it is the most common cancer that arises during the first year of life and the most common extracranial solid malignancy, representing 8–10% of all pediatric malignancies. Neuroblastoma is also responsible for 15% of childhood cancer mortality (Attiyeh et al. 2005; Brodeur 1997; Maris 2010). The median age at diagnosis is 17 months, and the incidence of the disease quickly dissipates with increasing age (Fig. 5.1).",

author = "Joseph Panoff and John Lucas and Luke Pater and Shefali Gajjar",

year = "2018",

month = jan

day = "1",

doi = "10.1007/978-3-319-43545-9_5",

language = "English (US)",

series = "Pediatric Oncology",

publisher = "Springer Verlag",

number = "9783319435442",

pages = "87--110",

booktitle = "Pediatric Oncology",

address = "Germany",

edition = "9783319435442",

}

TY - CHAP

T1 - Neuroblastoma

AU - Panoff, Joseph

AU - Lucas, John

AU - Pater, Luke

AU - Gajjar, Shefali

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Approximately 650 cases of neuroblastoma are diagnosed in the United States each year. With an incidence of 10.2 cases per million, it is the most common cancer that arises during the first year of life and the most common extracranial solid malignancy, representing 8–10% of all pediatric malignancies. Neuroblastoma is also responsible for 15% of childhood cancer mortality (Attiyeh et al. 2005; Brodeur 1997; Maris 2010). The median age at diagnosis is 17 months, and the incidence of the disease quickly dissipates with increasing age (Fig. 5.1).

AB - Approximately 650 cases of neuroblastoma are diagnosed in the United States each year. With an incidence of 10.2 cases per million, it is the most common cancer that arises during the first year of life and the most common extracranial solid malignancy, representing 8–10% of all pediatric malignancies. Neuroblastoma is also responsible for 15% of childhood cancer mortality (Attiyeh et al. 2005; Brodeur 1997; Maris 2010). The median age at diagnosis is 17 months, and the incidence of the disease quickly dissipates with increasing age (Fig. 5.1).

UR - http://www.scopus.com/inward/record.url?scp=85043257695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043257695&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-43545-9_5

DO - 10.1007/978-3-319-43545-9_5

M3 - Chapter

AN - SCOPUS:85043257695

T3 - Pediatric Oncology

SP - 87

EP - 110

BT - Pediatric Oncology

PB - Springer Verlag

ER -

Access to Document

10.1007/978-3-319-43545-9_5